Zhaowei Chen, from the Renmin Hospital of Wuhan University in China, and colleagues examined the efficacy of HCQ in treatment of COVID-19. Sixty-two patients with COVID-19 diagnosed and admitted from Feb. 4 to Feb. 28, 2020, were randomly assigned to receive an additional five-day HCQ treatment or standard treatment (control).
“Despite our small number of cases, the potential of HCQ in the treatment of COVID-19 has been partially confirmed. Considering that there is no better option at present, it is a promising practice to apply HCQ to COVID-19 under reasonable management,” the authors write. “However, large-scale clinical and basic research is still needed to clarify its specific mechanism and to continuously optimize the treatment plan.”
Read the original article here: https://medicalxpress.com/news/2020-04-hydroxychloroquine-shorten-recovery-covid–.html